Literature DB >> 25504379

Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Joanna S T Asprer1, Uma Lakshmipathy.   

Abstract

Pluripotent stem cells (PSCs) are powerful tools for basic scientific research and promising agents for drug discovery and regenerative medicine. Technological advances have made it increasingly easy to generate PSCs but the various lines generated may differ in their characteristics based on their origin, derivation, number of passages, and culture conditions. In order to confirm the pluripotency, quality, identity, and safety of pluripotent cell lines as they are derived and maintained, it is critical to perform a panel of characterization assays. Functional pluripotency is determined using tests that rely on the expression of specific markers in the undifferentiated and differentiated states; tests for quality, identity and safety are less specialized. This article provides a comprehensive review of current practices in PSC characterization and explores challenges in the field, from the selection of markers to the development of simple and scalable methods. It also delves into emerging trends like the adoption of alternative assays that could be used to supplement or replace traditional methods, specifically the use of in silico assays for determining pluripotency.

Entities:  

Mesh:

Year:  2015        PMID: 25504379     DOI: 10.1007/s12015-014-9580-6

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  163 in total

1.  Derivation, characterization, and differentiation of human embryonic stem cells.

Authors:  Nico Heins; Mikael C O Englund; Cecilia Sjöblom; Ulf Dahl; Anna Tonning; Christina Bergh; Anders Lindahl; Charles Hanson; Henrik Semb
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

2.  Lab-specific gene expression signatures in pluripotent stem cells.

Authors:  Aaron M Newman; James B Cooper
Journal:  Cell Stem Cell       Date:  2010-08-06       Impact factor: 24.633

Review 3.  Cell cross-contamination in cell cultures: the silent and neglected danger.

Authors:  O Markovic; N Markovic
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

Review 4.  Cross-contamination of cells in culture.

Authors:  W A Nelson-Rees; D W Daniels; R R Flandermeyer
Journal:  Science       Date:  1981-04-24       Impact factor: 47.728

5.  Methods for culturing human embryonic stem cells on feeders.

Authors:  Jasmeet Kaur; Mary Lynn Tilkins
Journal:  Methods Mol Biol       Date:  2013

6.  TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells.

Authors:  Sunali N Patel; Yalei Wu; Yun Bao; Ricardo Mancebo; Janice Au-Young; Elena Grigorenko
Journal:  Methods Mol Biol       Date:  2013

7.  Forced aggregation and defined factors allow highly uniform-sized embryoid bodies and functional cardiomyocytes from human embryonic and induced pluripotent stem cells.

Authors:  Martin Pesl; Ivana Acimovic; Jan Pribyl; Renata Hezova; Aleksandra Vilotic; Jeremy Fauconnier; Jan Vrbsky; Peter Kruzliak; Petr Skladal; Tomas Kara; Vladimir Rotrekl; Alain Lacampagne; Petr Dvorak; Albano C Meli
Journal:  Heart Vessels       Date:  2013-11-21       Impact factor: 2.037

8.  Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells.

Authors:  Philip Roelandt; Karen Ann Pauwelyn; Pau Sancho-Bru; Kartik Subramanian; Bipasha Bose; Laura Ordovas; Kim Vanuytsel; Martine Geraerts; Meri Firpo; Rita De Vos; Johan Fevery; Frederik Nevens; Wei-Shou Hu; Catherine M Verfaillie
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

Review 9.  Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.

Authors:  Vasundhra Kashyap; Naira C Rezende; Kymora B Scotland; Sebastian M Shaffer; Jenny Liao Persson; Lorraine J Gudas; Nigel P Mongan
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

10.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

View more
  3 in total

1.  Homogeneous Differentiation of Functional Hepatocytes from Human Induced Pluripotent Stem Cells.

Authors:  Rong Li; Yang Zhao; Jeffrey J Yourick; Robert L Sprando; Xiugong Gao
Journal:  Methods Mol Biol       Date:  2022

2.  Induced pluripotent stem cells from patients with focal cortical dysplasia and refractory epilepsy.

Authors:  Daniel Rodrigo Marinowic; Fernanda Majolo; Alessandra Deise Sebben; Vinicius Duval da Silva; Tiago Giuliani Lopes; Eliseu Paglioli; André Palmini; Denise Cantarelli Machado; Jaderson Costa da Costa
Journal:  Mol Med Rep       Date:  2017-03-01       Impact factor: 2.952

3.  Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.

Authors:  Behnam Ahmadian Baghbaderani; Adhikarla Syama; Renuka Sivapatham; Ying Pei; Odity Mukherjee; Thomas Fellner; Xianmin Zeng; Mahendra S Rao
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.